This page describes pharmacological agents that may have legal restrictions, side effects, and drug interactions in your jurisdiction. Information is for educational research only — consult a clinician before considering any compound.

Browse

Tretinoin (all-trans retinoic acid)

Emerging

Tretinoin is the gold-standard topical retinoid since 1971, with A-tier evidence for acne (any concentration) and photoaging (Kligman…

Aliases (9)
Retin-A · Retin-A Micro · Renova · Avita · Atralin · ATRA · all-trans retinoic acid · vitamin A acid · tretinoinum
TYPICAL DOSE
0.5 g
Nightly
ROUTE
Topical application
Topical application
CYCLE
Not generally needed
Continuous / as needed
STORAGE
Room temp; sealed
Room temp

Overview

What is Tretinoin (all-trans retinoic acid)?

Tretinoin (all-trans retinoic acid) is a topical retinoid FDA-approved for acne and photoaging, marketed as Retin-A and other brands. It is the gold-standard prescription topical for skin renewal, photoaging reversal, and inflammatory acne.

Key Benefits

Reduces acne (comedonal and inflammatory), reverses photoaging (fine lines, hyperpigmentation, texture), increases dermal collagen synthesis, and accelerates skin cell turnover. Long-term use is associated with measurable improvements in skin appearance.

Mechanism of Action

Binds nuclear retinoic acid receptors (RAR-α, RAR-β, RAR-γ), modulating gene transcription that controls keratinocyte differentiation, sebum production, and dermal extracellular matrix proteins. Increases collagen synthesis, normalizes follicular keratinization, and reduces melanogenesis.

Pharmacokinetics

·
PeakHalf-life
Approximate curve — visual aid only, not data-precise PK
Application protocol Topical
Vehicle
Cream / serum / gel
Frequency
Per label
Area
Face / target lesion (avoid eyes, lips, nostrils)
Pregnancy
Category C
  1. 1 Cleanse + dry skin. Pat skin dry; wait 15-20 min after washing for retinoids (reduces irritation). Skin must be fully dry — moisture amplifies penetration and irritation.
  2. 2 Pea-sized amount (or thin layer) for the entire treatment area. More is not better — irritation scales faster than efficacy.
  3. 3 Layering rules. Avoid combining with benzoyl peroxide (degrades retinoids), AHAs, or salicylic acid in the same routine. Niacinamide and ceramides are safe co-applications.
  4. 4 Sunscreen mandatory next AM. Most topicals (especially retinoids, hydroquinone) increase photosensitivity. SPF 30+ broad-spectrum minimum.
  5. 5 Ramp slowly. Start every-other-night for 2-4 weeks; increase to nightly only after tolerance builds. Skipping a night during peak irritation is the right move.

No systemic dosing required — topicals act locally with minimal serum absorption at standard doses.

Research Indications

Most Effective

RAR-α

broadly expressed

Effective

RAR-β

modulated in differentiation

Investigational

RAR-γ

*the predominant isoform in epidermis* (~90% of epidermal RAR), the main mechanism for tretinoin's keratinocyte effects

Research Protocols

Disclaimer: These are commonly discussed research protocols and not medical advice.

Goal:Generic tretinoin 0.025% cream 20 g tube
Dose:
Frequency:nightly
Solo:
Cycle:
Goal:Generic tretinoin 0.05% / 0.1% cream
Dose:
Frequency:
Solo:
Cycle:
Goal:Branded Retin-A Micro / Atralin
Dose:
Frequency:
Solo:
Cycle:
Goal:OTC adapalene 0.1% (Differin) 45 g
Dose:
Frequency:
Solo:
Cycle:

Peptide Interactions

niacinamide (topical 4-10%):
Synergistic

reduces tretinoin irritation, restores barrier, complementary anti-pigmentation. Apply niacinamide AM, tretinoin PM (or layer with niacinamide first if combi…

vitamin C (L-ascorbic acid 10-20%, topical AM):
Synergistic

synergistic anti-photoaging — vitamin C drives collagen crosslinking (lysyl oxidase cofactor), tretinoin drives collagen transcription. Apply vitamin C AM, t…

ghk-cu (topical):
Synergistic

complementary mechanism (signal-side collagen + barrier repair vs tretinoin's transcription effects). Apply GHK-Cu AM, tretinoin PM (timing-separated). The 2…

hyaluronic acid (topical):
Synergistic

simple humectant layer; reduces tretinoin dryness without efficacy loss.

azelaic acid 15-20% (topical):
Synergistic

anti-inflammatory + anti-comedonal + brightening; gentler partner with tretinoin; can alternate nights.

clindamycin (topical) or BPO (timing-separated for older formulations):
Synergistic

acne combination protocols.

oral doxycycline 100 mg/d × 6-12 weeks:
Synergistic

for moderate-severe inflammatory acne, paired with topical tretinoin.

Benzoyl peroxide (older tretinoin formulations, same-application):
Avoid

BPO oxidizes/deactivates tretinoin → loss of efficacy. Solution: BPO in AM, tretinoin in PM, OR use tretinoin microsphere (Retin-A Micro), which is BPO-stabl…

Salicylic acid, glycolic acid, lactic acid, other AHA/BHA exfoliants — same application:
Avoid

compound irritation. Use on alternate nights or separate AM/PM.

Hydroquinone — long-term:
Avoid

fine in Kligman's triple-combination protocol (8-12 weeks). Avoid chronic indefinite combination; risk of ochronosis with prolonged hydroquinone.

Waxing, threading, depilatory creams in the treated area:
Avoid

pause tretinoin 5-7 days before; risk of skin tearing.

IPL, laser resurfacing, chemical peels, microneedling:
Avoid

pause tretinoin 5-7 days before and after.

Quality Indicators

Stable cream/serum base

Should have a uniform texture, no separation, no off odor.

!

Color drift

Some actives oxidize when exposed to air or light; minor color shift can be normal.

Separation or off smell

Phase separation, mold, or strong rancid odor indicates degraded product — discard.

What to Expect

  • Week 1-2
    Application protocol established. Watch for irritation.
  • Week 4
    Early visible/measurable change. Most topicals are slow.
  • Week 8-12
    Meaningful effect window for most topical actives.
  • Month 6+
    Maintenance phase. Stopping reverses gains over weeks-months.

Side Effects & Safety 10

Side Effects

  1. 1Erythema — mild-to-moderate redness
  2. 2Scaling, peeling, dryness — most prominent first 4-6 weeks
  3. 3Stinging or burning on application — reduces with tolerance
  4. 4Initial acne purge — week 2-6 (mechanism-correct; resolves)
  5. 5Photosensitivity — mechanistic; AM SPF mandatory
  6. 6Pruritus — mild itching during retinization
  7. 7Persistent irritation beyond week 8 — reduce frequency, lower concentration, increase moisturizer buffering
  8. 8Hyperpigmentation in skin of color from over-irritation — be more conservative with titration in Fitzpatrick IV-VI
  9. 9Hypopigmentation (rare; usually transient)
  10. 10Worsening of pre-existing eczema, rosacea, or perioral dermatitis ← *the user flag*

When to Stop

  • Severe contact dermatitis / sensitization — discontinue
  • Precipitation or major flare of perioral/periorificial dermatitis ← *the archetype-specific risk*
  • Paradoxical acne worsening if overused (chronic irritation → barrier compromise → microbial dysbiosis → more acne)
  • Eye irritation if applied too close to eyes; avoid periorbital application without specific indication
  • Pregnancy: ABSOLUTE CONTRAINDICATION (Category C; some sources Category D for the related etretinate / acitretin oral retinoids, but topical tretinoin in pregnancy is also contraindicated by FDA labeling). Topical absorption is low (~2%) but the safety margin is too thin given retinoids' known teratogenicity. Discontinue 1 month before planned conception.
  • Active perioral dermatitis, rosacea flare, severe eczema — relative contraindication; pursue underlying-condition treatment first
  • Recent IPL, laser resurfacing, chemical peels, dermabrasion, waxing of treated area — pause tretinoin 5-7 days before/after; combination → severe irritation
  • Sunburn / acute UV damage — pause until resolved
  • Weeks 1-4: monitor for excessive irritation; should be tolerable, not painful. If painful, reduce to 1×/week or switch to adapalene.
  • Weeks 4-8: purge phase. Differentiate "purge" (small comedones surfacing) from "POD precipitation" (red papules + scaling around mouth/nose/eyes — NOT comedones).
  • Months 3-6: assess benefit/tolerability balance. Adjust concentration or frequency.
  • Long-term: continued use is fine; barrier function should be normal once tolerized.

References

Kligman AM et al. *Topical tretinoin for photoaged skin.* J Am Acad Dermatol 1986

pubmed.ncbi.nlm.nih.gov · 1986

original photoaging RCT

View Study

Weinstein GD et al. *Topical tretinoin for treatment of photodamaged skin: a multicenter study.* Arch Dermatol 1991

pubmed.ncbi.nlm.nih.gov · 1991

confirmatory multicenter trial

View Study

Cochrane review: topical retinoids for acne vulgaris

cochranelibrary.com

meta-analysis of retinoid efficacy

View Study

American Academy of Dermatology — Acne Guidelines 2024

aad.org · 2024

first-line topical retinoid recommendation

View Study

Tolaymat L, Hall MR. *Perioral Dermatitis.* StatPearls 2023

ncbi.nlm.nih.gov · 2023

POD pathogenesis + management; lists topical retinoids as triggers

View Study
Was this helpful?
Your feedback shapes what we research deeper.

How was your experience with this compound?

Anonymous · one vote per session · results below at 5+ votes.

Loading…

See something off?

Most of this wiki is AI-generated. Suggest a correction, dosing update, or new evidence — we review every submission.

Discussion — click to load
Loading…
Continue: Extended research →
Our verdict, decision matrix, deep dives, controversies, sources

Related compounds

Cross-referenced from Tretinoin (all-trans retinoic acid)

More in Topical

6 compounds in bucket